Uğur BERBEROĞLU, Fatma MARKOÇ, Emine KURT, Sevim TURANLI

How to manage pseudoangiomatous stromal hyperplasia: our clinical experience

Background/aim: Pseudoangiomatous stromal hyperplasia (PASH) is a rare and benign mesenchymal proliferative breast lesion. Our aim is to review the clinical and radiological features of PASH and define a standard approach for its diagnosis and management. Materials and methods: Clinical records of 35 consecutive patients with PASH were retrospectively reviewed between 2009 and 2015. Patients with clinically or radiologically detected mass and patients who underwent biopsy for other indications and were diagnosed incidentally were included in the study. Results: There were 34 female patients and one male patient with gynecomastia. Twenty-three patients had palpable masses, and 16 of them were diagnosed as PASH with a median size of 3.1 cm. PASH did not show any specific features in radiological imaging. Core needle biopsy was performed for 3 patients before surgical excision; however, the lesions had not been diagnosed as PASH. In pathological examination, lesions associated with PASH showed nonproliferative changes in 14 patients, proliferative changes without atypia in 17, one phyllodes tumor, one in situ tumor, and one invasive cancer. Conclusion: Imaging findings of PASH are nonspecific. It is difficult to give a true prognostic diagnosis through pathological evaluation of big masses with core needle biopsy. We recommend surgical excision, especially for big lesions with suspicious features.

PDF

___

1. Vuitch MF, Rosen PP, Erlandson RA. Pseudoangiomatous hyperplasia of mammary stroma. Hum Pathol 1986; 17: 185- 191.
2. Ibrahim RE, Sciotto CG, Weidner N. Pseudoangiomatous hyperplasia of mammary stroma. Some observations regarding its clinicopathologic spectrum. Cancer 1989; 63: 1154-1160.
3. Abdullgaffar B. Pseudoangiomatous stromal hyperplasia of the breast. Arch Pathol Lab Med 2009; 133: 1335-1338.
4. Sng KK, Tan SM, Mancer JF, Tay KH. The contrasting presentation and management of pseudoangiomatous stromal hyperplasia of the breast. Singapore Med J 2008; 49: e82-e85.
5. Hargaden GC, Yeh ED, Georgian-Smith D, Moore RH, Rafferty EA, Halpern EF, McKee GT. Analysis of the mammographic and sonographic features of pseudoangiomatous stromal hyperplasia. AJR Am J Roentgenol 2008; 191: 359-363.
6. Celliers L, Wong DD, Bourke A. Pseudoangiomatous stromal hyperplasia: a study of the mammographic and sonographic features. Clin Radiol 2010; 65: 145-149.
7. Jones KN, Glazebrook KN, Reynolds C. Pseudoangiomatous stromal hyperplasia: imaging findings with pathologic and clinical correlation. Am J Roentgenol 2010; 195: 1036-1042.
8. Fisher CJ, Hanby AM, Robinson L, Millis RR. Mammary hamartoma: a review of 35 cases. Histopathology 1992; 20: 99- 106.
9. Gresik CM, Godellas C, Aranha GV, Rajan P, Shoup M. Pseudoangiomatous stromal hyperplasia of the breast: a contemporary approach to its clinical and radiologic features and ideal management. Surgery 2010; 148: 752-758.
10. Bowman E, Oprea G, Okoli J, Gundry K, Rizzo M, GabramMendola S, Manne U, Smith G, Pambuccian S, Bumpers HL. Pseudoangiomatous stromal hyperplasia (PASH) of the breast: a series of 24 patients. Breast J 2012; 18: 242-247.
11. Anderson C, Ricci A Jr, Pederson CA, Cartun RW. Immunocytochemical analysis of estrogen and progesterone receptors in benign stromal lesions of the breast. Evidence for hormonal etiology in pseudoangiomatous hyperplasia of mammary stroma. Am J Surg Pathol 1991; 15: 145-149.
12. Vogel PM, Georgiade NG, Fetter BF, Vogel FS, McCarty KS Jr. The correlation of histologic changes in the human breast with the menstrual cycle. Am J Pathol 1981; 104: 23-34.
13. Shehata BM, Fishman I, Collings MH, Wang J, Poulik JM, Ricketts RR, Parker PM, Heiss K, Bhatia AM, Worchester HD et al. Pseudoangiomatous stromal hyperplasia of the breast in pediatric patients: an underrecognized entity. Pediatr Dev Pathol 2009; 12: 450-454.
14. Raj SD, Sahani VG, Adrada BE, Scoggins ME, Albarracin CT, Woodtichartpreecha P, Monetto FEP, Whitman GJ. Pseudoangiomatous stromal hyperplasia of the breast: multimodality review with pathologic correlation. Curr Probl Diagn Radiol 2016; 46: 130-135.
15. Protos A, Nguyen KT, Caughran JL, Naski M, Keto JL. Pseudoangiomatous stromal hyperplasia on core needle biopsy does not require surgical excision. Am Surg 2016; 82: 117-121.
16. Joshi M, Reddy SJ, Nanavidekar M, Russo JP, Russo AV, Pathak R. Core biopsies of the breast: diagnostic pitfalls. Indian J Pathol Microbiol 2011; 54: 671-682.
17. Drinka EK, Bargaje A, Erşahin ÇH, Patel P, Salhadar A, Sinacore J, Rajan P. Pseudoangiomatous stromal hyperplasia (PASH) of the breast: a clinicopathological study of 79 cases. Int J Surg Pathol 2012; 20: 54-58.
18. Amin AL, Purdy AC, Mattingly JD, Kong AL. Benign breast disease. Surg Clin N Am 2013; 93: 299-308.
19. Jayasinghe Y, Simmons PS. Fibroadenomas in adolescence. Curr Opin Obstet Gynecol 2009; 21: 402-406.
20. Nassar H, Elieff MP, Kronz JD, Argani P. Pseudoangiomatous stromal hyperplasia (PASH) of the breast with foci of morphologic malignancy: a case of PASH with malignant transformation?. Int J Surg Pathol 2010; 18: 564-569.
21. Cohen MA, Morris EA, Rosen PP, Dershaw DD, Liberman L, Abramson AF. Pseudoangiomatous stromal hyperplasia: mammographic, sonographic, and clinical patterns. Radiology 1996; 198: 117-120.
22. Solomou E, Kraniotis P, Patriarcheas G. A case of giant pseudoangiomatous stromal hyperplasia of the breast: magnetic resonance imaging findings. Rare Tumors 2012; 12: e23.
23. Polger MR, Denison CM, Lester S, Meyer JE. Pseudoangiomatous stromal hyperplasia: mammographic and sonographic appearances. Am J Roentgenol 1996; 166: 349- 352.